Evidence map›Paper›PMID 38110375›Full record

SynthesisBMJ open2023

New methodology to assess the excess burden of antibiotic resistance using country-specific parameters: a case study regarding

Noortje Grejanne Godijk, Scott A McDonald, Wieke Altorf-van der Kuil, Annelot F Schoffelen, Eelco Franz, Martin C J Bootsma

Open access · goldAbstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Noortje Grejanne GodijkJulius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands n.g.godijk@gmail.com.
Scott A McDonaldCentre for Infectious Disease Control, National Institute for Public Health & the Environment, Bilthoven, The Netherlands.ORCID 0000-0003-0788-6011
Wieke Altorf-van der KuilCentre for Infectious Disease Control, National Institute for Public Health & the Environment, Bilthoven, The Netherlands.
Annelot F SchoffelenCentre for Infectious Disease Control, National Institute for Public Health & the Environment, Bilthoven, The Netherlands.
Eelco FranzCentre for Infectious Disease Control, National Institute for Public Health & the Environment, Bilthoven, The Netherlands.
Martin C J BootsmaJulius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.
National Institute for Public Health and the Environment · NLUniversity Medical Center Utrecht · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAntimicrobial resistant (AMR) infections are a major public health problem and the burden on population level is not yet clear. We developed a method to calculate the

designExcess burden was estimated using the incidence-based disability-adjusted life-years (DALYs) measure. Incidence of AMR

resultsThe annual excess burden of AMR

conclusionsFor the first time, we use country-specific and pathogen-specific parameters to estimate the excess burden of resistant infections. Given the large difference in excess burden due to resistance estimated for Italy and for the Netherlands, we emphasise the importance of using country-specific parameters describing the incidence and disease progression following AMR and susceptible infections that are pathogen specific, and unfortunately currently difficult to locate.

Indexed as

Anti-Infective AgentsEscherichia coli InfectionsUrinary Tract InfectionsAnti-Bacterial AgentsDrug Resistance, MicrobialEscherichia coliHumansAnti-Bacterial AgentsAnti-Infective Agentsepidemiologyinfectious diseasespublic healthqualitative researchstatistics & research methodsurinary tract infections

Identifiers

PMID38110375
OpenAlexW4389914068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.